Recludix Pharma
Travis Grant has been working in the field of research since 2018. Travis began their career as a Research Intern at Pfizer in 2018, before moving to AlivaMab Discovery Services in 2021, where they served as a Research Associate II. Most recently, they joined Recludix Pharma in 2022, where they currently work as an Associate Scientist.
Travis Grant obtained a Bachelor of Science in Biomedical Sciences, General from Liberty University between 2017 and 2020.
Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity.